Patent · US Active

Method for the production of permanent human cell lines

US9371512B2 · kind B2 · utility

1Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2010
Grant dateJun 21, 2016
Priority date
Expiry dateFeb 5, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/24
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a permanent human cell line comprising a nucleic acid sequence for the adenoviral gene functions E1A and E1B and the nucleic acid sequence for the SV40 large T-antigen or the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1). Further, the present invention relates to a method for transient expression of recombinant polypeptides and proteins in said permanent human cell line.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.